Teemu Suna

Founder & CEO @NgaleHealth. Accelerating Preventive Medicine and Finnish Business. Oh, and Icefishing.

[Teemu Suna @teemusuna]

Interviewed by @gemmamilne for @Forbes: If something fails, it doesn’t prove that someone else cannot make it work - @NgaleHealth looking beyond Theranos https://t.co/HWavZSGGRA

[Teemu Suna @teemusuna]

@AnttiLuiro @Vuornos @NgaleHealth Ikä+sukupuoli+pieni määrä verta riittää ja tarjoaa huipputason kansansairauksien riskintunnistuskyvyn https://t.co/uqm5u5gyxC  3/3

[Teemu Suna @teemusuna]

@AnttiLuiro @Vuornos @NgaleHealth Silloin kuormitus pienenee, syntyy säästöjä ja parempaa terveyttä. Nightingale lienee yksi erittäin harvoista realistisista ratkaisuista joka on kansalliseen käyttöön riittävän edullinen, operatiivisesti yksinkertainen. 2/3

[Nightingale Health @NgaleHealth]

We've launched Livit by Nightingale Health. From a finger-prick sample, we deliver our new Healthy Years estimate together with a wide variety of other health metrics that not only measure your current health but also predict the future of your health.
https://t.co/qxV0QUO9KD

[Teemu Suna @teemusuna]

We are redefining global primary care by empowering people with modern preventative health tools - read more👇🏼

[Nightingale Health @NgaleHealth]

We are featured on the cover and in a 7-page article "Nightingale Is Reinventing Preventative Health One Blood Draw at a Time" in StartUp Health Magazine. The article gives an excellent overview of our mission, technology, recent achievements, and more.
https://t.co/TTQTnmuDH2

[StartUp Health @startuphealth]

🎙️ This week's podcast is with #HealthTransformer @teemusuna, CEO & Co-founder of @NgaleHealth, who shared how Nightingale's blood-testing technology could change preventative health #globally. Listen here! https://t.co/OWr2kLgwqx

[Teemu Suna @teemusuna]

Indeed - however, this needs to be built for mass market and we @NgaleHealth are already on it! 💪

[Jari Valtanen @JariValtanen]

@danielgross @NgaleHealth will do the same - except only cheaper 😉

Or actually, it already does 😆
https://t.co/zBVsRmWbwi

[Nightingale Health @NgaleHealth]

Earlier today, we held a virtual event, An hour with Nightingale, where our CEO @teemusuna and CSO @jcbarret shared our most recent research and development achievements.
Watch the recording: https://t.co/y9SgxFoUSo

[TEHDAS2 joint action @tehdas]

We're excited to have @SamuMyllykangas and @teemusuna join #TEHDASforum on 27 October.
They will share how their companies utilise #healthdata, how they overcame barriers to data use, and how they see data changing healthcare.
Register today! https://t.co/WrF4SCSVoD

[Teemu Suna @teemusuna]

Exciting news & important step in our global expansion plan - great work Team Nightingale! 💪

[Nightingale Health @NgaleHealth]

Nightingale receives CE marking for its at-home blood collection kit. Read more: https://t.co/BtYQsexXoL

[Teemu Suna @teemusuna]

Nightingale’s Financial Statement Release is out. Great delivery, speed & progress in key strategic iniatives. Thank you Team Nightingale, fantastic job (once again)!

[Nightingale Health @NgaleHealth]

Nightingale Health Plc's Financial Statements Release for financial year July 2020 – June 2021 has been released. You can read it here: https://t.co/Vowki9zywn

A recording of our webcast where we presented the achievements of the financial year: https://t.co/HUerifJenn

[Teemu Suna @teemusuna]

Millä tolalla on tuoreen pörssiyhtiön toimitusjohtajan terveys? Katso haastattelun alussa miten Nightingalen testi paljastaa totuuden pintaa syvemmältä. https://t.co/C55z5SIMT7

[Teemu Suna @teemusuna]

Delighted to have @jcbarret join Nightingale as Chief Scientific Officer to accelerate our mission to bring preventative health tools available worldwide.

[Nightingale Health @NgaleHealth]

Nightingale has appointed internationally recognised scientific leader Jeffrey Barrett as Chief Scientific Officer.
Read release: https://t.co/OHCRcHmiUO

[Nightingale Health @NgaleHealth]

Nightingalen listautumisanti on ylimerkitty ja listautuminen toteutetaan suunnitellusti – B-sarjan osakkeiden kaupankäynnin odotetaan alkavan perjantaina 19.3.2021

https://t.co/CtwArc7JJj

[Nightingale Health @NgaleHealth]

The IPO of Nightingale has been oversubscribed and the listing will be completed as planned – trading in the series B shares is expected to commence on Friday 19 March 2021

https://t.co/MMuXhBB1fs

[Nightingale Health @NgaleHealth]

Nightingale intends to launch an IPO and listing on Nasdaq First North Growth Market Finland. Read more: https://t.co/R7e6RqCy2n

[Nightingale Health @NgaleHealth]

Nightingale Health suunnittelee listautumista Nasdaq Helsingin First North markkinapaikalle. Lue
lisää: https://t.co/RtJReC5K5S

[Elon Musk @elonmusk]

@teslaownersSV Well, back to work …

[Nightingale Health @NgaleHealth]

#BigNews Nightingale has appointed Swedbank AB as the lead financial advisor to explore different financing options, including possibilities of an Initial Public Offering by listing the Company’s shares on Nasdaq Helsinki First North.

Details: https://t.co/te8rUFVtSg

[Teemu Suna @teemusuna]

Matka kohti pörssiä alkaa @NgaleHealth https://t.co/9cES87n6ow